References

Arbyn, M., C. Bergeron, P. Klinkhamer, P. Martin-Hirsch, A.G. Siebers and J. Bulten, 2008. Liquid compared with conventional cervical cytology: A systematic review and meta-analysis. Obstet. Gynecol., 111: 167-177.

Bhaumik, J., S. Mahadevan and A.E. Davies, 2004. The value of human papillomavirus testing in the colposcopy clinic. J. Obstet. Gynaecol., 24: 817-819.

Cubie, H.A., 2007. Papillomaviruses and Polyomaviruses. In: Medical Microbiology, Greenwood, D., R. Slack, J. Peutherer and M. Barer (Eds.). 17th Edn., Vol. 45, Churchill Livingsone Elsevier, United Kingdom, pp: 446-456.

Dannecker, C., U. Siebert, C.J. Thaler, D. Kiermeir, H. Hepp and P. Hillemanns, 2004. Primary cervical cancer screening by self-sampling of human papillomavirus DNA in internal medicine outpatient clinics. Ann. Oncol., 15: 863-869.
CrossRef  |  

Disaia, P.J. and W.T. Creasman, 2002. Clinical Gynaecologic Oncology. 6th Edn., Mosby Inc., California, USA.

Huang, S.L., A. Chao, S. Hsueh, F.Y. Chao and C.C. Huang et al., 2006. Comparison between the hybrid capture II test and an SPF1/GP6+ PCR-based assay for detection of human papillomavirus DNA in Cervical Swab samples. J. Clin. Microbiol., 44: 1733-1739.
CrossRef  |  

International Agency for Research on Cancer, 2005. Cervix Cancer Screening (IARC Handbooks of Cancer Prevention). 1st Edn., World Health Organization, IARC Press, Lyon, France, ISBN-10: 9283230108.

Kim, J.J., T.C. Wright and S.J. Goldie, 2005. Cost-effectiveness of human papillomavirus DNA testing in the United Kingdom, The Netherlands, France and Italy. J. Natl. Cancer Inst., 97: 888-895.
PubMed  |  

Legood, R., A. Gray, J. Wolstenholme and S. Moss, 2006. Lifetime effects, costs and cost effectiveness of testing for human papillomavirus to manage low grade cytological abnormalities: Results of the NHS pilot studies. BMJ., 332: 79-85.
CrossRef  |  

Liverani, M., F.D. Paola, S. Danesi, R. Fedriga and V. Dalbuoni et al., 2006. Applicative aspects of liquid-based cytology in cervical cancer screening. Pathologica, 98: 629-634.
PubMed  |  

Manivasagam, R., P.M. Flynn and B.S. Bolger, 2004. Hysterectomy for abnormal cervical cytology following treatment for cervical intra-epithelial neoplasia. J. Obstet. Gynaecol., 24: 72-73.
PubMed  |  

Moss, S.A., A. Gray, R. Legood, M. Vessey and J. Patnick et al., 2006. Effect of testing for human papillomavirus as a triage during screening for cervical cancer: Observational before and after study. BMJ., 332: 83-85.
PubMed  |  

Nobbenhuis, M.A., T.J. Helmerhorst, A.J. van den Brule, L. Rozendaal and L.H. Jaspars et al., 2002. Primary screening for high risk HPV by home obtained cervicovaginal lavage is an alternative screening tool for unscreened women. J. Clin. Pathol., 55: 435-439.
PubMed  |  

Palefsky, J., 2002. What Your Doctor May Not Tell You About HPV and Abnormal Pap Smears. Warner Books, New York, USA.

Passmore, J.A.S., C. Morroni, S. Shapiro, A.L. Williamson and M. Hoffman, 2007. Papanicolaou smears and cervical inflammatory cytokine responses. J. Inflamm. (Lond.), 4: 8-8.

Quint, W.G.V., S.R. Pagliusi, N. Lelie, E.M. de Villiers and C.M. Wheeler, 2006. Results of the first world health organization international collaborative study of detection of human papillomavirus. J. Clin. Microbiol., 44: 571-579.

Sirovich, B.E. and H.G. Welch, 2004. The frequency of pap smear screening in the United States. J. Genet. Int. Med., 19: 243-250.

Smith, M., L. French and H.C. Barry, 2003. Periodic Abstinence from Pap (PAP) smear study: Women's perceptions of pap smear screening. Ann. Family Med., 1: 203-208.
Direct Link  |  

Stevens, M.P., S.M. Garland, E. Rudland, J. Tan, M.A. Quinn and S.N. Tabrizi, 2007. Comparison of the digene hybrid capture 2 assay and Roche AMPLICOR and LINEAR ARRAY human papillomavirus (HPV) tests in detecting high-risk HPV. J. Clin. Microbiol., 45: 2130-2137.
PubMed  |  

Van Ham, M.A.P.C., J.M.J.E. Bakkers, G.K. Harbers, W.G.V. Quint, L.F.A.G., Massuger and W.J.G. Melchers, 2005. Comparison of 2 commercial Assays for detection of human papillomavirus (HPV) in cervical scrape specimens: Validation of the Roche AMPLICOR HPV test as a means to screen for HPV genotypes associated with a higher risk of cervical disorders. J. Clin. Microbiol., 43: 2662-2667.
CrossRef  |  

WHO/IARC., 1995. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans: Human Papillomaviruses. Vol. 64, World Health Organization, International Agency for Research on Cancer, UK., ISBN-13: 9789283212645.

Watts, G., 2007. Commentary: Liquid automation refreshes Dr. Papanicolaou. BMJ., 335: 35-36.
CrossRef  |  

Yoshida, T., T. Fukuda, T. Sano, T. Kanuma, N. Owada and T. Nakajima, 2004. Usefulness of liquid-based cytology specimens for the immunocytochemical study of p16 expression and human papillomavirus testing: A comparative study using simultaneously sampled histology materials. Cancer, 102: 100-108.
PubMed  |